February 27 - March 2, 2023 | Part of BPI West
San Diego Convention CenterSan Diego, CAKey Sessions
Cokey Nguyen
Off-The-Shelf Allogeneic EBV CAR T Cells
Atara Biotherapeutics
Michael Klichinsky
Development of CAR-M: Harnessing Macrophages to Eliminate Tumors
Carisma Therapeutics Inc.
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
2023 Agenda Day 1 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
2023 Agenda Day 1 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
7:00am - 8:00am60 mins
Coffee and Registration
8:00am - 8:10am10 mins
Conference Opening and Welcome
8:10am - 8:50am40 mins
Plenary Session
How Technology, Big Data, and Systems Approaches are Transforming 21st Century Healthcare
- Leroy Hood - Co-founder, Professor and Chief Strategy Officer, Institute for Systems Biology
8:50am - 9:30am40 mins
Plenary Session
Facility of the Future - Design Philosophy and Vision for New Clinical Supply Center
- Jeff Davis - Executive Director, Head of SSF Clinical Supply Center, Genentech
9:30am - 10:25am55 mins
Networking Refreshment Break
10:25am - 10:30am5 mins
Next Generation CAR & T Cell Therapies
Chairperson's Remarks
10:25am - 10:30am5 mins
Cell & Gene Therapy Manufacturing
Chairperson's Remarks
10:30am - 11:00am30 mins
Next Generation CAR & T Cell Therapies
Development of CAR-M: Harnessing Macrophages to Eliminate Tumors
- Michael Klichinsky - Co-Founder and Chief Scientific Officer, Carisma Therapeutics Inc.
10:30am - 11:00am30 mins
Cell & Gene Therapy Manufacturing
Quality In, Quality Out: The Impact of Critical Starting Materials on rAAV Production using Transient Transfection
- Yizhou Zhou, PhD - Head of Cell Line Technology, Gene Therapy Development, Biogen
11:00am - 11:30am30 mins
Next Generation CAR & T Cell Therapies
Restoring the Immune Balance with Regulatory T cell Therapies in Inflammatory and Auto-immune Diseases
- Nathalie Belmonte - Sr VP Research & Translation, Quell Therapeutics
11:00am - 11:30am30 mins
Cell & Gene Therapy Manufacturing
Cell Line Development and Engineering Innovations to Increase Yields for Gene Therapies Products
- Saurabh Sen - Associate Director, Cell Line Development, Sanofi
11:30am - 12:00pm30 mins
Next Generation CAR & T Cell Therapies
Scientific Track Presentation
11:30am - 12:00pm30 mins
Cell & Gene Therapy Manufacturing
Scientific Track Presentation
12:00pm - 1:25pm85 mins
Sponsored Luncheon Presentations
1:25pm - 1:30pm5 mins
Next Generation CAR & T Cell Therapies
Chairperson's Remarks
1:25pm - 1:30pm5 mins
Cell & Gene Therapy Manufacturing
Chairperson's Remarks
1:30pm - 2:00pm30 mins
Next Generation CAR & T Cell Therapies
Off-The-Shelf Allogeneic EBV CAR T Cells
- Cokey Nguyen - Senior Vice President, Chief Scientific Officer, Atara Biotherapeutics
1:30pm - 2:00pm30 mins
Cell & Gene Therapy Manufacturing
Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach
- Huiren Zhao - Scientist, Amgen Inc.
2:00pm - 2:30pm30 mins
Next Generation CAR & T Cell Therapies
A New Approach to Building an Allogeneic Manufacturing Platform
- Jeff Liter - CEO & Founder, Luminary Therapeutics
2:00pm - 2:30pm30 mins
Cell & Gene Therapy Manufacturing
Leveraging Small Molecule Enhancers to Improve AAV Productivity
- Dan Comiskey - Scientist II, Sarepta Therapeutics
2:30pm - 3:00pm30 mins
Next Generation CAR & T Cell Therapies
Scientific Track Presentation
2:30pm - 3:00pm30 mins
Cell & Gene Therapy Manufacturing
Scientific Track Presentation
3:00pm - 4:00pm60 mins
Networking Refreshment Break in Exhibit & Poster Hall
4:00pm - 4:30pm30 mins
Next Generation CAR & T Cell Therapies
Development of Anti-CD19 CAR T-Cell Therapy for Autoimmune Diseases
- James Chung, M.D., PhD. - Chief Medical Officer, Kyverna Therapeutics
4:00pm - 4:30pm30 mins
Cell & Gene Therapy Manufacturing
AEX Enrichment of AAV5 Full Capsids with Dual Salt Elution Gradients
- Ashton Lavoie - Head of Downstream Process Development, BridgeBio Gene Therapy (BridgeBio Pharma)
4:30pm - 5:00pm30 mins
Next Generation CAR & T Cell Therapies
Transient Epigenetic Reprogramming Enhances CAR-T-cell Proliferation and Tumor Killing
- Mustafa Turkoz - Head of Immunology, Turn Biotechnologies
4:30pm - 5:00pm30 mins
Cell & Gene Therapy Manufacturing
Viral Safety of Gene Therapy Products: Approaches to Viral Clearance for AAV Gene Therapy Products
- Samantha Jones - Senior Manager, Process Development, Tenaya Therapeutics
5:00pm - 6:30pm90 mins
Cocktail Reception in Exhibit & Poster Hall
Get the latest event updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats